Source: BEFREE
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TNF receptor superfamily member 11b | 0.422 | 0.808 | 0.16 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
iduronate 2-sulfatase | 0.559 | 0.769 | 0.95 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
dickkopf WNT signaling pathway inhibitor 3 | 0.500 | 0.731 | 4.1E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
transforming growth factor beta induced | 0.484 | 0.769 | 6.0E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2017 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2009 | 2018 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2016 | 2019 | ||||||||
|
envoplakin | 0.599 | 0.423 | 5.7E-25 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 1998 | 2019 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2009 | 2016 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.909 | 11 | 3 | 2005 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 1993 | 2019 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.942 | 69 | 0 | 1992 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.100 | None | 0.958 | 24 | 1 | 2009 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.975 | 159 | 0 | 1993 | 2020 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.300 | None | 0.979 | 516 | 12 | 2005 | 2020 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.500 | None | 0.979 | 91 | 4 | 1995 | 2020 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
disease | 0.100 | None | 0.980 | 102 | 0 | 2014 | 2020 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 34 | 0 | 1998 | 2018 | ||||||||
|
sterol O-acyltransferase 1 | 0.424 | 0.846 | 7.4E-10 |
|
disease | 0.100 | None | 1.000 | 33 | 0 | 2006 | 2020 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.300 | None | 1.000 | 24 | 0 | 2003 | 2019 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 2008 | 2016 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2003 | 2018 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2008 | 2018 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2008 | 2018 |